Axsome Therapeutics Inc (AXSM)

Precedente Chiudi:

$73.76

Aprire:

$74.03

Volume 24 ore:

453.69K

Capitalizzazione di mercato:

$3.56B

Reddito:

$270.60M

Utile/perdita netta:

$-239.24M

Rapporto P/E:

-16.53

EPS:

-4.53

Flusso di cassa netto:

$-145.66M

1 W Prestazione:

+5.23%

1M Prestazione:

-2.73%

6M Prestazione:

+15.89%

1 anno Prestazione:

+5.82%

Intervallo 1D:

$73.28

$76.39

Portata 52W:

$55.02

$98.40

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Nome

Axsome Therapeutics Inc

Settore

Healthcare (1189)

Industria

Biotechnology (685)

Telefono

212-332-3241

Indirizzo

25 Broadway, 9th Floor, New York

Dipendente

27

Cinguettio

Prossima data di guadagno

2024-05-06

Ultimi documenti SEC

AXSM's Discussions on Twitter

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-06	Iniziato	UBS	Buy
2024-01-25	Iniziato	RBC Capital Mkts	Outperform
2023-12-13	Iniziato	Citigroup	Buy
2023-08-08	Aggiornamento	BofA Securities	Underperform → Neutral
2023-01-05	Iniziato	Piper Sandler	Neutral
2022-11-01	Iniziato	Loop Capital	Buy
2022-09-07	Ripresa	Mizuho	Buy
2021-08-10	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-06-10	Iniziato	Berenberg	Buy
2021-01-08	Iniziato	Jefferies	Buy
2020-12-16	Iniziato	Mizuho	Buy
2020-09-29	Iniziato	BofA Securities	Underperform
2020-09-10	Iniziato	Morgan Stanley	Overweight
2020-04-28	Reiterato	H.C. Wainwright	Buy
2020-04-14	Iniziato	Cowen	Outperform
2019-12-30	Reiterato	H.C. Wainwright	Buy
2019-12-17	Reiterato	H.C. Wainwright	Buy
2019-12-16	Reiterato	Guggenheim	Buy
2019-10-16	Iniziato	Guggenheim	Buy
2019-09-18	Iniziato	William Blair	Outperform
2019-05-28	Iniziato	SunTrust	Buy
2019-05-23	Reiterato	H.C. Wainwright	Buy
2019-04-08	Iniziato	SVB Leerink	Outperform
2019-03-15	Reiterato	H.C. Wainwright	Buy
2016-10-03	Ripresa	Brean Capital	Buy
2015-12-15	Iniziato	Cantor Fitzgerald	Buy
2015-12-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks Investment Research

Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights

Benzinga

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline

Zacks Investment Research

Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

The Motley Fool

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

GlobeNewswire Inc.

Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study

Zacks Investment Research

Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari

Axsome Therapeutics Inc (AXSM) Reddito 2024

Axsome Therapeutics Inc (AXSM) Reddito netto 2024

Axsome Therapeutics Inc (AXSM) Flusso di cassa 2024

Axsome Therapeutics Inc (AXSM) Utile per azione 2024

Axsome Therapeutics Inc Azioni (AXSM) insider trading